| 1 |
33450506 | BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca2+-dependent mPTP opening. | 2021 Mar |
1 |
| 2 |
34400171 | Tracing the evolutionary history of Ca2+-signaling modulation by human Bcl-2: Insights from the Capsaspora owczarzaki IP3 receptor ortholog. | 2021 Nov |
3 |
| 3 |
29899382 | Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2. | 2019 Mar |
1 |
| 4 |
29330143 | Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10. | 2018 Mar 15 |
2 |
| 5 |
30053503 | Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones. | 2018 Nov |
1 |
| 6 |
29340082 | Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax. | 2017 Dec 19 |
2 |
| 7 |
27494888 | The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition. | 2016 Aug 23 |
3 |
| 8 |
26317541 | A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. | 2015 Sep 29 |
1 |
| 9 |
24768714 | A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. | 2014 Oct |
2 |
| 10 |
22955373 | The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond. | 2013 Apr |
2 |
| 11 |
21818117 | Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. | 2012 Feb |
8 |
| 12 |
21193695 | Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. | 2011 Mar 10 |
3 |
| 13 |
19056433 | Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. | 2009 Jun |
1 |
| 14 |
19706527 | The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. | 2009 Aug 25 |
4 |